| Drug giant AstraZeneca is reviewing the "single event" that caused the illness during Phase 3 of Oxford's coronavirus vaccine trials. The interruption represents the first major hiccup in what has been a smooth path in the rapid vaccine effort spanning the globe. |  |
News Alert Tuesday, September 8 |
|
| | | | | | | | |
|
